Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Digirad Corporation to Present at the Sidoti & Co. Fall 2016 Emerging Growth Convention

Posted on: 12 Oct 16

SUWANEE, Ga., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ:DRAD) announced today that Matt Molchan will be presenting on behalf of the company at the Sidoti Fall 2016 Emerging Growth Convention to be held at the Marriott Marquis in New York, NY on Tuesday, November 1, 2016.

Event: Sidoti Fall 2016 Emerging Growth Convention
When:Tuesday, November 1 2016
Where:New York Marriott Marquis – 5th Floor
 1535 Broadway, New York, NY 10036 (45th & Broadway)

Matt Molchan, Digirad's President and CEO, will provide an overview of the Company's business during a live presentation on Tuesday, November 1, at 9:50 a.m. ET.   Investors interested in attending and scheduling a one-on-one meeting with management should visit the link below:

A live webcast of the presentation will be available from the Events & Presentations link on the Investor Relations page of the Digirad website at or by following the link below:

For general information about the event, please visit the conference website below:

About Digirad
Digirad delivers convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis.  Digirad’s diverse portfolio of mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring, provides hospitals, physician practices, and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment.  For more information, please visit

About the Sidoti Emerging Growth Convention
The Sidoti Fall 2016 Emerging Growth Convention will focus on companies with market capitalizations of $600 million and less, connecting their executive management teams with Wall Street’s top small- and micro-cap institutional and high-net-worth investors, research and investment banking professionals and other key stakeholders in the micro-cap investment community.  The convention will feature approximately 75 public companies with solid franchises. Past attendance comprised approximately 400 investment professionals, including nearly 275 registered institutional investors.

About Sidoti & Company, LLC
Founded in 1999, Sidoti & Company has become the leading provider of equity research focused on publicly-traded companies with market capitalizations of generally less than $3 billion.  Our coverage universe comprises nearly 300 equities across a broad array of industries.  Most of these companies have a history of profitability and balance sheet strength.  Our clients are the leading institutional investors in the small- and micro-cap markets in the U.S., Canada and the U.K.  Our approach affords institutional investor clients a combination of high-quality research, a small- and micro-cap company focused nationwide sales effort, broad access to corporate management teams, and extensive trading support.   For more information, please refer to



Last updated on: 13/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.